Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARNEST: Second-line HIV Therapy Options in Africa
NCT00988039Phase 3Completed
- Start
- Mar 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV). Started Mar 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00988039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988039.